The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.
MAPS speaks with Amit Lalwani, omnichannel lead and member of the Core Planning Team for the MAPA/MAPS Medical Affairs Summit, Nov 8-10, 2023 in Sydney, AU.
Kesselring will work with the MAPS Professional Development Committee to assist with the creation of courses supporting 7 Medical Affairs competency certification tracks identified in the MAPS 5-year strategic plan.
This white paper addresses insights challenges in Strategy, Data Generation, and Analysis/Reporting – arming Medical Affairs teams with the tools and opportunity to build strategies that preempt these challenges.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
In this podcast, we interview Matt Lewis, Chief AI Officer at Inizio Medical, a well-regarded expert in data analytics and augmented intelligence.
In this podcast, experts from the “Optimize your Field Medical Team for the Omnichannel World” workshop at the MAPS 2023 America’s Conference discuss the outcomes & insights of that workshop & how Field Medical can build skills & garner support to effectively implement omnichannel strategies.